LBP AM SA purchased a new position in Centene Corporation (NYSE:CNC - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm purchased 15,516 shares of the company's stock, valued at approximately $942,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Ameriflex Group Inc. acquired a new stake in Centene during the 4th quarter worth $26,000. Pinney & Scofield Inc. acquired a new stake in Centene during the 4th quarter worth approximately $25,000. Hurley Capital LLC acquired a new stake in Centene in the 4th quarter valued at $26,000. Studio Investment Management LLC acquired a new position in Centene in the 4th quarter valued at about $32,000. Finally, Golden State Wealth Management LLC grew its holdings in shares of Centene by 203.1% during the 1st quarter. Golden State Wealth Management LLC now owns 579 shares of the company's stock worth $35,000 after purchasing an additional 388 shares in the last quarter. Institutional investors own 93.63% of the company's stock.
Centene Price Performance
Shares of NYSE CNC traded down $1.10 during mid-day trading on Friday, hitting $31.42. 15,513,063 shares of the company's stock traded hands, compared to its average volume of 5,764,398. The company's 50-day moving average is $53.79 and its two-hundred day moving average is $58.30. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.11 and a quick ratio of 1.11. The company has a market capitalization of $15.63 billion, a P/E ratio of 4.68, a PEG ratio of 0.48 and a beta of 0.44. Centene Corporation has a 1 year low of $31.39 and a 1 year high of $80.59.
Centene (NYSE:CNC - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $2.90 earnings per share for the quarter, topping analysts' consensus estimates of $2.52 by $0.38. The company had revenue of $46.62 billion for the quarter, compared to analyst estimates of $43.16 billion. Centene had a net margin of 2.04% and a return on equity of 14.56%. The firm's revenue for the quarter was up 15.4% on a year-over-year basis. During the same period in the prior year, the company posted $2.26 EPS. On average, equities analysts anticipate that Centene Corporation will post 6.86 EPS for the current fiscal year.
Analyst Ratings Changes
A number of research analysts have recently commented on the stock. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $48.00 target price (down previously from $75.00) on shares of Centene in a report on Wednesday, July 2nd. Jefferies Financial Group decreased their target price on Centene from $64.00 to $61.00 and set a "hold" rating for the company in a research report on Tuesday, April 29th. Wall Street Zen lowered Centene from a "strong-buy" rating to a "buy" rating in a report on Monday, April 28th. Guggenheim reaffirmed a "neutral" rating on shares of Centene in a research report on Tuesday, April 29th. Finally, UBS Group reiterated a "neutral" rating and set a $45.00 target price (down previously from $80.00) on shares of Centene in a research report on Wednesday, July 2nd. Twelve investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $64.75.
Read Our Latest Stock Analysis on CNC
Centene Profile
(
Free Report)
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
See Also

Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.